Cellular and Molecular Mechanisms in Oxidative Stress-Related Diseases 2.0

© 2024 by the authors; CC BY-NC-ND license

glutathione; coronavirus; SARS-CoV-2; COVID-19; vaccines; reactive oxygen species; Pb²⁺; toxicology; endoplasmic reticulum stress; apoptosis; somatic segment development; interstitial cystitis; bladder pain syndrome; biomarker; cytokine; resveratrol; NMDA receptor; salicylate; excitotoxicity; tinnitus; microplastic; cadmium; kidney; oxidative stress; autophagy; kidney transplant; hypothermic machine perfusion; organ preservation; ROS; metabolomic; EPR; ¹H-NMR; oxidative damage; reactive oxygen species; singlet oxygen; biomarkers; lipid peroxidation; athletes; bone mineral density; bone mineral content; osteoporosis; SOD2; GPx; CAPE; oxidative stress; ARPE−19 cells; UCP2; oxidative stress; immunomodulation; reactive oxygen and nitrogen species; redox homeostasis; antioxidant; innate immunity; adaptive immunity; antiviral therapy; plasma; type 2 diabetes; genetic susceptibility; molecular mechanisms; oxidative stress; redox homeostasis; glutathione metabolism; antioxidant enzymes; oxidative enzymes; single nucleotide polymorphism; apelin; APJ; apelinergic system; oxidative stress; obstructive sleep apnea syndrome; OSAS; OSA; oxidative stress; intermittent hypoxia; biomarkers; CPAP; cognitive; oxidative stress; CYLD; disease; deubiquitination; Camellia sinensis seeds; theasaponin E1; assamsaponin A; antifungal activity; transcriptome; n/a; metals; orthodontic appliance; prooxidant effect; cytotoxicity; genotoxicity; gastrointestinal tract cell lines; poisoning; carbon monoxide; oxidative stress; treatment options; n/a